| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,216 |
7,332 |
$316K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
941 |
884 |
$56K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,443 |
2,602 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
108 |
96 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
716 |
333 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
197 |
186 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,077 |
944 |
$3K |
| 99051 |
|
216 |
201 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
27 |
27 |
$2K |
| 94760 |
|
1,013 |
888 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
70 |
50 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
806 |
701 |
$782.90 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
86 |
71 |
$697.92 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
22 |
19 |
$677.61 |
| 81002 |
|
158 |
150 |
$352.69 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
443 |
384 |
$337.08 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,079 |
940 |
$235.76 |
| 82947 |
|
14 |
14 |
$27.27 |
| 36415 |
Collection of venous blood by venipuncture |
15 |
13 |
$24.30 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
13 |
12 |
$5.37 |
| 99072 |
|
71 |
68 |
$0.00 |
| 3008F |
|
199 |
196 |
$0.00 |
| 99000 |
|
252 |
241 |
$0.00 |